BSSM Algorithm Premature Ejaculation v4
BSSM Algorithm Premature Ejaculation v4
BSSM Algorithm Premature Ejaculation v4
Although reliable information on the prevalence of lifelong and acquired PE is lacking when based upon patient self-report, PE is the most common
male sexual dysfunction. Lifelong PE is defined as:
‘A male sexual dysfunction characterised by ejaculation which always or nearly always occurs prior to or within about one minute of vaginal penetration and
the inability to delay ejaculation on all or nearly all vaginal penetrations, and negative personal consequences, such as distress, bother, frustration and/or the
avoidance of sexual intimacy.’
To help you manage PE appropriately, we have proposed the following algorithm to guide you through the treatment options.
It is important to distinguish between Erectile PATIENT/PARTNER HISTORY Six questions that can help to identify PE are:
Dysfunction (ED) and PE so the following
questions are useful: • Establish presenting complaint • Can you delay ejaculation before vaginal penetration?
• Time taken to ejaculate after vaginal • What is the time between penetration and ejaculation?
• Is your erection hard enough to penetrate? penetration • Can you delay ejaculation?
• Do you have difficulty in maintaining your erection • Perceived degree of ejaculatory control • Do you and/or your partner feel bothered, annoyed,
until you ejaculate during intercourse? • Degree of patient/partner distress and/or frustrated by your PE?
• Do you ever rush intercourse to prevent loss of your • Onset and duration of PE • Is your PE affecting your relationship?
erection? • Psychological history • Do you and/or your partner avoid sexual intercourse
• Medical history because of embarrassment?
NO YES
PE
PE LIKE
EJACULATORY NATURAL
VARIABLE YES
DYSFUNCTION
• Reassurance NO
• Education
• Psychotherapy
Lifelong and acquired PE can be
• Behavioural therapy
differentiated by enquiring:
ACQUIRED PE LIFELONG PE
TREATMENT TREATMENT
• Behavioural/psychotherapy • Pharmacotherapy
• Pharmacotherapy PATIENT • Behavioural/psychotherapy
• Combination treatment PREFERENCE • Combination treatment
TREATMENT OPTIONS
Pharmacotherapy
Oral therapies:
• Short half-life on demand SSRIs specifically suggesting a role in treating PE e.g. dapoxetine - which is the only oral licensed medication for the treatment of PE
• Off label SSRIs and TCAs that have been used as a daily treatment for PE e.g. paroxetine, sertraline, fluoxetine, citalopram and clomipramine
• PDE5 inhibitors used on demand as a combination treatment with SSRIs, when PE co-exists with ED
• Tramadol, an opiate derivative (usually used as an analgesic) but could be used where PE co-exists with a need for analgesia
Topical therapies:
• Off label lidocaine/prilocaine
Behavioural/psychological
Therapies have been incorporated for a number of years but quantitative research shows benefit is not forthcoming. Nevertheless many patients are understandably anxious and may appreciate
psychotherapy.
Algorithm is based on guidance from The International Society of Sexual Medicine (The Journal of Sexual Medicine 2010; 7:2947-2969)
SSRI: Selective Serotonin Reuptake Inhibitor TCA: Tricyclic Antidepressant PDE5: phosphodiesterase type 5 This algorithm has been independently produced by BSSM. Support and funding has been provided by A. Menarini Farmaceutica Internazionale SRL